|
|
regulation of muscle contraction
|
GO:0006937 |
3 |
0.914
|
|
|
|
myofibril assembly
|
GO:0030239 |
48 |
0.745
|
|
|
|
muscle structure development
|
GO:0061061 |
196 |
0.745
|
|
|
|
heart development
|
GO:0007507 |
313 |
0.637
|
|
|
|
actin filament based movement
|
GO:0030048 |
1 |
0.579
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
2 |
0.576
|
|
|
|
muscle contraction
|
GO:0006936 |
18 |
0.575
|
Rat |
|
|
cardiac chamber formation
|
GO:0003207 |
4 |
0.543
|
|
|
|
negative regulation of blood circulation
|
GO:1903523 |
2 |
0.537
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
110 |
0.531
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
53 |
0.460
|
|
|
|
regulation of mechanoreceptor differentiation
|
GO:0045631 |
1 |
0.431
|
|
|
|
tube morphogenesis
|
GO:0035239 |
349 |
0.429
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
133 |
0.398
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
3 |
0.393
|
|
|
|
fluid transport
|
GO:0042044 |
17 |
0.380
|
|
|
|
striated muscle cell development
|
GO:0055002 |
108 |
0.379
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
50 |
0.371
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
31 |
0.362
|
|
|
|
negative regulation of heart contraction
|
GO:0045822 |
2 |
0.348
|
|
|
|
actin filament based process
|
GO:0030029 |
64 |
0.348
|
|
|
|
positive regulation of heart contraction
|
GO:0045823 |
2 |
0.335
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
20 |
0.320
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
2 |
0.300
|
|
|
|
heart morphogenesis
|
GO:0003007 |
156 |
0.299
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
108 |
0.292
|
|
|
|
cellular component biogenesis
|
GO:0044085 |
178 |
0.289
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
148 |
0.287
|
|
|
|
regulation of system process
|
GO:0044057 |
40 |
0.277
|
|
|
|
specification of symmetry
|
GO:0009799 |
204 |
0.276
|
|
|
|
cation homeostasis
|
GO:0055080 |
33 |
0.271
|
|
|
|
atrial cardiac myofibril assembly
|
GO:0055004 |
2 |
0.266
|
|
|
|
larval development
|
GO:0002164 |
2 |
0.260
|
|
|
|
transmembrane transport
|
GO:0055085 |
120 |
0.258
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
44 |
0.250
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
65 |
0.248
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
1 |
0.242
|
|
|
|
adult behavior
|
GO:0030534 |
2 |
0.238
|
|
|
|
organelle assembly
|
GO:0070925 |
110 |
0.230
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
4 |
0.229
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
26 |
0.227
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
1 |
0.222
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
57 |
0.203
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
48 |
0.203
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
91 |
0.201
|
|
|
|
heart jogging
|
GO:0003146 |
40 |
0.198
|
|
|
|
ventricular cardiac muscle cell development
|
GO:0055015 |
5 |
0.196
|
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
129 |
0.189
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
4 |
0.188
|
|
|
|
cell migration involved in heart development
|
GO:0060973 |
22 |
0.183
|
|
|
|
atrial cardiac muscle cell development
|
GO:0055014 |
4 |
0.178
|
|
|
|
regulation of multicellular organismal process
|
GO:0051239 |
277 |
0.174
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
32 |
0.173
|
|
|
|
muscle organ development
|
GO:0007517 |
101 |
0.170
|
Rat |
|
|
heart looping
|
GO:0001947 |
94 |
0.169
|
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
271 |
0.165
|
Worm |
|
|
calcium ion import
|
GO:0070509 |
4 |
0.161
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
4 |
0.158
|
|
|
|
atp catabolic process
|
GO:0006200 |
4 |
0.154
|
|
|
|
regulation of cardiac muscle cell contraction
|
GO:0086004 |
1 |
0.150
|
|
|
|
heart contraction
|
GO:0060047 |
71 |
0.146
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
30 |
0.146
|
|
|
|
cardiac ventricle formation
|
GO:0003211 |
1 |
0.141
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
107 |
0.127
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
139 |
0.126
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
7 |
0.126
|
|
|
|
cellular response to lipid
|
GO:0071396 |
39 |
0.125
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
22 |
0.118
|
|
|
|
sodium ion import
|
GO:0097369 |
3 |
0.118
|
|
|
|
heart process
|
GO:0003015 |
71 |
0.109
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
12 |
0.108
|
|
|
|
system process
|
GO:0003008 |
185 |
0.108
|
|
|
|
muscle system process
|
GO:0003012 |
20 |
0.108
|
Rat |
|
|
morphogenesis of an epithelium
|
GO:0002009 |
333 |
0.108
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
32 |
0.105
|
|
|
|
signal transduction
|
GO:0007165 |
455 |
0.104
|
|
|
|
muscle tissue development
|
GO:0060537 |
110 |
0.102
|
|
|
|
cardiac atrium morphogenesis
|
GO:0003209 |
2 |
0.100
|
|
|
|
endocardial cushion formation
|
GO:0003272 |
2 |
0.097
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
179 |
0.096
|
|
|
|
regulation of heart morphogenesis
|
GO:2000826 |
17 |
0.094
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
2 |
0.093
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
117 |
0.090
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
4 |
0.089
|
|
|
|
mesodermal to mesenchymal transition involved in gastrulation
|
GO:0060809 |
1 |
0.084
|
|
|
|
atrioventricular valve formation
|
GO:0003190 |
3 |
0.084
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
17 |
0.084
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
1 |
0.083
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
2 |
0.081
|
|
|
|
monovalent inorganic cation transport
|
GO:0015672 |
42 |
0.080
|
|
|
|
response to lipid
|
GO:0033993 |
60 |
0.080
|
|
|
|
regulation of biological quality
|
GO:0065008 |
263 |
0.078
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
63 |
0.078
|
|
|
|
single organism localization
|
GO:1902578 |
225 |
0.077
|
|
|
|
organelle organization
|
GO:0006996 |
227 |
0.077
|
|
|
|
apical junction assembly
|
GO:0043297 |
1 |
0.077
|
|
|
|
neuron fate determination
|
GO:0048664 |
2 |
0.076
|
|
|
|
muscle cell development
|
GO:0055001 |
115 |
0.075
|
|
|
|
aorta development
|
GO:0035904 |
4 |
0.074
|
|
|
|
specification of organ axis polarity
|
GO:0010084 |
2 |
0.074
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
274 |
0.073
|
|
|
|
metal ion transport
|
GO:0030001 |
58 |
0.071
|
|
|
|
lipid storage
|
GO:0019915 |
1 |
0.071
|
|
|
|
maintenance of location
|
GO:0051235 |
4 |
0.070
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
21 |
0.070
|
|
|
|
endocardial cushion morphogenesis
|
GO:0003203 |
3 |
0.069
|
|
|
|
determination of bilateral symmetry
|
GO:0009855 |
204 |
0.068
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
2 |
0.067
|
|
|
|
organic cyclic compound metabolic process
|
GO:1901360 |
301 |
0.066
|
|
|
|
regulation of cell matrix adhesion
|
GO:0001952 |
1 |
0.066
|
|
|
|
peptide metabolic process
|
GO:0006518 |
1 |
0.065
|
|
|
|
regulation of response to stimulus
|
GO:0048583 |
269 |
0.062
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
1 |
0.060
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
13 |
0.059
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
336 |
0.059
|
|
|
|
regulation of tube size
|
GO:0035150 |
2 |
0.059
|
|
|
|
regulation of cardiac chamber formation
|
GO:1901210 |
2 |
0.055
|
|
|
|
pharyngeal muscle development
|
GO:0043282 |
4 |
0.055
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
13 |
0.054
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
4 |
0.054
|
|
|
|
cellular cation homeostasis
|
GO:0030003 |
17 |
0.053
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
3 |
0.052
|
|
|
|
ion homeostasis
|
GO:0050801 |
41 |
0.052
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
4 |
0.051
|
|
|
|
regulation of metabolic process
|
GO:0019222 |
359 |
0.050
|
|
|
|
determination of left right asymmetry in nervous system
|
GO:0035545 |
4 |
0.050
|
|
|
|
cellular sodium ion homeostasis
|
GO:0006883 |
1 |
0.049
|
|
|
|
heart valve formation
|
GO:0003188 |
4 |
0.049
|
|
|
|
blood circulation
|
GO:0008015 |
87 |
0.049
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
19 |
0.049
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
2 |
0.048
|
|
|
|
ventricular cardiac muscle cell differentiation
|
GO:0055012 |
6 |
0.047
|
|
|
|
muscle organ morphogenesis
|
GO:0048644 |
8 |
0.047
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.045
|
|
|
|
pericardium development
|
GO:0060039 |
1 |
0.045
|
|
|
|
aging
|
GO:0007568 |
2 |
0.045
|
|
|
|
establishment of localization
|
GO:0051234 |
244 |
0.045
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
2 |
0.044
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
55 |
0.044
|
|
|
|
regulation of cardiac chamber morphogenesis
|
GO:1901219 |
2 |
0.044
|
|
|
|
nitrogen compound metabolic process
|
GO:0006807 |
319 |
0.042
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
2 |
0.042
|
|
|
|
cardioblast migration to the midline involved in heart rudiment formation
|
GO:0003319 |
5 |
0.041
|
|
|
|
heart field specification
|
GO:0003128 |
1 |
0.041
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
7 |
0.041
|
|
|
|
blood vessel endothelial cell differentiation
|
GO:0060837 |
2 |
0.040
|
|
|
|
response to alkaloid
|
GO:0043279 |
2 |
0.040
|
|
|
|
embryonic organ development
|
GO:0048568 |
381 |
0.039
|
|
|
|
organonitrogen compound metabolic process
|
GO:1901564 |
74 |
0.039
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
2 |
0.039
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
4 |
0.038
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
2 |
0.037
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
39 |
0.037
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
16 |
0.037
|
|
|
|
immune system process
|
GO:0002376 |
241 |
0.036
|
|
|
|
single organism metabolic process
|
GO:0044710 |
217 |
0.036
|
|
|
|
cation transport
|
GO:0006812 |
81 |
0.036
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
4 |
0.036
|
|
|
|
regulation of localization
|
GO:0032879 |
104 |
0.036
|
|
|
|
catabolic process
|
GO:0009056 |
32 |
0.035
|
|
|
|
sodium ion transport
|
GO:0006814 |
24 |
0.034
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
1 |
0.034
|
|
|
|
organophosphate metabolic process
|
GO:0019637 |
37 |
0.033
|
|
|
|
heterocycle metabolic process
|
GO:0046483 |
290 |
0.033
|
|
|
|
hemopoiesis
|
GO:0030097 |
183 |
0.032
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
130 |
0.032
|
|
|
|
transport
|
GO:0006810 |
220 |
0.032
|
|
|
|
protein import
|
GO:0017038 |
3 |
0.032
|
|
|
|
response to hormone
|
GO:0009725 |
48 |
0.031
|
|
|
|
sarcomere organization
|
GO:0045214 |
26 |
0.031
|
|
|
|
embryonic skeletal joint development
|
GO:0072498 |
3 |
0.031
|
|
|
|
regulation of sodium ion transport
|
GO:0002028 |
2 |
0.030
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
1 |
0.030
|
|
|
|
glucocorticoid metabolic process
|
GO:0008211 |
2 |
0.030
|
|
|
|
circulatory system process
|
GO:0003013 |
87 |
0.030
|
|
|
|
catechol containing compound metabolic process
|
GO:0009712 |
2 |
0.030
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
4 |
0.029
|
|
|
|
cardiac chamber development
|
GO:0003205 |
19 |
0.029
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
2 |
0.029
|
|
|
|
negative regulation of muscle contraction
|
GO:0045932 |
1 |
0.029
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
5 |
0.029
|
|
|
|
dorsal aorta morphogenesis
|
GO:0035912 |
3 |
0.028
|
|
|
|
cell migration involved in heart formation
|
GO:0060974 |
10 |
0.028
|
|
|
|
cellular aromatic compound metabolic process
|
GO:0006725 |
295 |
0.028
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
4 |
0.028
|
|
|
|
cell motility
|
GO:0048870 |
244 |
0.028
|
|
|
|
oligodendrocyte cell fate specification
|
GO:0021778 |
4 |
0.028
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
7 |
0.028
|
|
|
|
glial cell migration
|
GO:0008347 |
3 |
0.027
|
|
|
|
regulation of binding
|
GO:0051098 |
3 |
0.026
|
|
|
|
cellular nitrogen compound metabolic process
|
GO:0034641 |
290 |
0.026
|
|
|
|
protein metabolic process
|
GO:0019538 |
183 |
0.025
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
21 |
0.025
|
|
|
|
response to mechanical stimulus
|
GO:0009612 |
24 |
0.025
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
1 |
0.025
|
|
|
|
venous blood vessel morphogenesis
|
GO:0048845 |
3 |
0.025
|
|
|
|
cardiac conduction system development
|
GO:0003161 |
1 |
0.025
|
|
|
|
dorsal aorta development
|
GO:0035907 |
4 |
0.025
|
|
|
|
specification of axis polarity
|
GO:0065001 |
4 |
0.024
|
|
|
|
cellular component assembly
|
GO:0022607 |
170 |
0.024
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
3 |
0.024
|
|
|
|
regulation of hematopoietic progenitor cell differentiation
|
GO:1901532 |
1 |
0.024
|
|
|
|
cellular component movement
|
GO:0006928 |
335 |
0.024
|
|
|
|
regulation of transport
|
GO:0051049 |
45 |
0.024
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
3 |
0.024
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
1 |
0.024
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
4 |
0.023
|
|
|
|
cytoskeleton organization
|
GO:0007010 |
96 |
0.023
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
3 |
0.023
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
2 |
0.023
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
6 |
0.023
|
Rat |
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
2 |
0.023
|
|
|
|
regulation of translational initiation
|
GO:0006446 |
1 |
0.022
|
|
|
|
antimicrobial humoral response
|
GO:0019730 |
2 |
0.022
|
|
|
|
locomotory behavior
|
GO:0007626 |
34 |
0.022
|
|
|
|
multi organism reproductive process
|
GO:0044703 |
36 |
0.022
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
1 |
0.022
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
2 |
0.022
|
|
|
|
cellular localization
|
GO:0051641 |
97 |
0.022
|
|
|
|
cardiac cell development
|
GO:0055006 |
21 |
0.022
|
|
|
|
homeostatic process
|
GO:0042592 |
142 |
0.021
|
|
|
|
regulation of membrane repolarization
|
GO:0060306 |
1 |
0.021
|
|
|
|
oxoacid metabolic process
|
GO:0043436 |
31 |
0.021
|
|
|
|
cellular monovalent inorganic cation homeostasis
|
GO:0030004 |
2 |
0.021
|
|
|
|
cellular response to chemical stimulus
|
GO:0070887 |
157 |
0.021
|
|
|
|
lipid catabolic process
|
GO:0016042 |
4 |
0.021
|
|
|
|
heart rudiment development
|
GO:0003313 |
8 |
0.021
|
|
|
|
definitive hemopoiesis
|
GO:0060216 |
18 |
0.021
|
|
|
|
regulation of bmp signaling pathway involved in heart jogging
|
GO:2000223 |
12 |
0.021
|
|
|
|
er nucleus signaling pathway
|
GO:0006984 |
2 |
0.020
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
3 |
0.020
|
|
|
|
atrial cardiac muscle cell differentiation
|
GO:0055011 |
5 |
0.020
|
|
|
|
regulation of cell communication
|
GO:0010646 |
232 |
0.020
|
|
|
|
synaptic growth at neuromuscular junction
|
GO:0051124 |
2 |
0.020
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
38 |
0.020
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
62 |
0.020
|
|
|
|
regulation of nucleobase containing compound metabolic process
|
GO:0019219 |
250 |
0.020
|
|
|
|
negative regulation of cellular process
|
GO:0048523 |
283 |
0.020
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
3 |
0.020
|
|
|
|
single organism organelle organization
|
GO:1902589 |
199 |
0.020
|
|
|
|
regulation of transmembrane transporter activity
|
GO:0022898 |
2 |
0.020
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
93 |
0.020
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
17 |
0.019
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
4 |
0.019
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
55 |
0.019
|
|
|
|
translational initiation
|
GO:0006413 |
3 |
0.019
|
|
|
|
intracellular signal transduction
|
GO:0035556 |
85 |
0.019
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
2 |
0.019
|
|
|
|
response to external stimulus
|
GO:0009605 |
264 |
0.019
|
|
|
|
nucleobase containing compound metabolic process
|
GO:0006139 |
274 |
0.019
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
3 |
0.018
|
|
|
|
cardiogenic plate morphogenesis
|
GO:0003142 |
1 |
0.018
|
|
|
|
protein targeting to nucleus
|
GO:0044744 |
3 |
0.018
|
|
|
|
regulation of neurotransmitter secretion
|
GO:0046928 |
1 |
0.018
|
|
|
|
regulation of skeletal muscle cell differentiation
|
GO:2001014 |
1 |
0.018
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
4 |
0.018
|
|
|
|
membrane hyperpolarization
|
GO:0060081 |
1 |
0.018
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
2 |
0.018
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
20 |
0.018
|
|
|
|
establishment of localization in cell
|
GO:0051649 |
77 |
0.018
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
4 |
0.017
|
|
|
|
monocyte differentiation
|
GO:0030224 |
2 |
0.017
|
|
|
|
carbohydrate derivative metabolic process
|
GO:1901135 |
61 |
0.017
|
|
|
|
erythrocyte development
|
GO:0048821 |
24 |
0.017
|
|
|
|
small molecule metabolic process
|
GO:0044281 |
77 |
0.017
|
|
|
|
organic acid metabolic process
|
GO:0006082 |
31 |
0.017
|
|
|
|
regulation of actin filament based movement
|
GO:1903115 |
1 |
0.017
|
|
|
|
central nervous system development
|
GO:0007417 |
387 |
0.017
|
|
|
|
death
|
GO:0016265 |
121 |
0.016
|
|
|
|
response to steroid hormone
|
GO:0048545 |
35 |
0.016
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
27 |
0.016
|
|
|
|
axon guidance
|
GO:0007411 |
86 |
0.016
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
9 |
0.016
|
|
|
|
cardiac myofibril assembly
|
GO:0055003 |
9 |
0.016
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
9 |
0.016
|
|
|
|
regulation of sequestering of calcium ion
|
GO:0051282 |
4 |
0.016
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
4 |
0.016
|
|
|
|
glial cell fate specification
|
GO:0021780 |
4 |
0.016
|
|
|
|
negative regulation of stem cell differentiation
|
GO:2000737 |
2 |
0.016
|
|
|
|
atrioventricular valve morphogenesis
|
GO:0003181 |
6 |
0.016
|
|
|
|
specification of organ identity
|
GO:0010092 |
2 |
0.016
|
|
|
|
phosphate containing compound metabolic process
|
GO:0006796 |
108 |
0.016
|
|
|
|
striated muscle contraction
|
GO:0006941 |
12 |
0.015
|
Rat |
|
|
phosphorus metabolic process
|
GO:0006793 |
109 |
0.015
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
32 |
0.015
|
|
|
|
caudal fin development
|
GO:0033336 |
9 |
0.015
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
78 |
0.015
|
Rat |
|
|
establishment of mitotic spindle localization
|
GO:0040001 |
12 |
0.015
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
7 |
0.015
|
|
|
|
positive regulation of transport
|
GO:0051050 |
2 |
0.015
|
|
|
|
action potential
|
GO:0001508 |
19 |
0.015
|
|
|
|
organic substance biosynthetic process
|
GO:1901576 |
289 |
0.015
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
1 |
0.014
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
2 |
0.014
|
|
|
|
organic substance catabolic process
|
GO:1901575 |
28 |
0.014
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
1 |
0.014
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
1 |
0.014
|
|
|
|
response to endogenous stimulus
|
GO:0009719 |
83 |
0.014
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
85 |
0.014
|
|
|
|
cellular biosynthetic process
|
GO:0044249 |
286 |
0.014
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
28 |
0.014
|
|
|
|
pronephros development
|
GO:0048793 |
69 |
0.014
|
|
|
|
neuron projection morphogenesis
|
GO:0048812 |
161 |
0.014
|
|
|
|
embryonic camera type eye formation
|
GO:0060900 |
10 |
0.014
|
|
|
|
positive regulation of skeletal muscle tissue development
|
GO:0048643 |
1 |
0.014
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
13 |
0.014
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
1 |
0.014
|
|
|
|
plasma membrane repair
|
GO:0001778 |
2 |
0.014
|
|
|
|
single organism transport
|
GO:0044765 |
206 |
0.014
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
1 |
0.014
|
|
|
|
organic cyclic compound biosynthetic process
|
GO:1901362 |
223 |
0.014
|
|
|
|
endocardial cushion development
|
GO:0003197 |
6 |
0.014
|
|
|
|
primitive hemopoiesis
|
GO:0060215 |
27 |
0.013
|
|
|
|
erythrocyte homeostasis
|
GO:0034101 |
55 |
0.013
|
|
|
|
cell surface receptor signaling pathway
|
GO:0007166 |
325 |
0.013
|
|
|
|
artery development
|
GO:0060840 |
22 |
0.013
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
3 |
0.013
|
|
|
|
compound eye development
|
GO:0048749 |
2 |
0.013
|
|
|
|
negative regulation of striated muscle tissue development
|
GO:0045843 |
2 |
0.013
|
|
|
|
syncytium formation
|
GO:0006949 |
12 |
0.013
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
2 |
0.013
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
3 |
0.013
|
|
|
|
cellular homeostasis
|
GO:0019725 |
26 |
0.013
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
2 |
0.013
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
23 |
0.013
|
|
|
|
regulation of cell proliferation involved in heart morphogenesis
|
GO:2000136 |
2 |
0.013
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
27 |
0.013
|
|
|
|
response to unfolded protein
|
GO:0006986 |
2 |
0.013
|
|
|
|
regulation of establishment of planar polarity
|
GO:0090175 |
4 |
0.013
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
10 |
0.013
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
60 |
0.013
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
3 |
0.013
|
|
|
|
lipid metabolic process
|
GO:0006629 |
52 |
0.013
|
|
|
|
carboxylic acid metabolic process
|
GO:0019752 |
22 |
0.013
|
|
|
|
fatty acid beta oxidation
|
GO:0006635 |
1 |
0.013
|
|
|
|
endoplasmic reticulum unfolded protein response
|
GO:0030968 |
2 |
0.012
|
|
|
|
specification of organ position
|
GO:0010159 |
3 |
0.012
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
2 |
0.012
|
|
|
|
segmentation
|
GO:0035282 |
97 |
0.012
|
|
|
|
mitochondrion organization
|
GO:0007005 |
4 |
0.012
|
|
|
|
multi organism process
|
GO:0051704 |
134 |
0.012
|
|
|
|
cellular response to unfolded protein
|
GO:0034620 |
2 |
0.012
|
|
|
|
nuclear import
|
GO:0051170 |
3 |
0.012
|
|
|
|
biosynthetic process
|
GO:0009058 |
294 |
0.012
|
|
|
|
regulation of cellular metabolic process
|
GO:0031323 |
320 |
0.012
|
|
|
|
regulation of organ growth
|
GO:0046620 |
3 |
0.012
|
|
|
|
cell cell signaling
|
GO:0007267 |
52 |
0.012
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
79 |
0.012
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
80 |
0.012
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
10 |
0.012
|
|
|
|
neuromuscular synaptic transmission
|
GO:0007274 |
2 |
0.012
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
2 |
0.012
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
1 |
0.012
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
3 |
0.012
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
28 |
0.012
|
|
|
|
post embryonic organ development
|
GO:0048569 |
4 |
0.012
|
|
|
|
nuclear transport
|
GO:0051169 |
4 |
0.011
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
1 |
0.011
|
|
|
|
pronephric duct development
|
GO:0039022 |
13 |
0.011
|
|
|
|
macromolecular complex assembly
|
GO:0065003 |
35 |
0.011
|
|
|
|
regulation of skeletal muscle tissue development
|
GO:0048641 |
4 |
0.011
|
|
|
|
negative regulation of biological process
|
GO:0048519 |
304 |
0.011
|
|
|
|
cell surface receptor signaling pathway involved in heart development
|
GO:0061311 |
20 |
0.011
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
55 |
0.011
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
3 |
0.011
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
1 |
0.011
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
5 |
0.011
|
|
|
|
post embryonic morphogenesis
|
GO:0009886 |
4 |
0.011
|
|
|
|
negative regulation of muscle tissue development
|
GO:1901862 |
2 |
0.011
|
|
|
|
regulation of inner ear receptor cell differentiation
|
GO:2000980 |
1 |
0.011
|
|
|
|
canonical wnt signaling pathway involved in heart development
|
GO:0061316 |
1 |
0.011
|
|
|
|
glucocorticoid biosynthetic process
|
GO:0006704 |
1 |
0.011
|
|
|
|
myoblast fusion
|
GO:0007520 |
10 |
0.011
|
|
|
|
endocardium formation
|
GO:0060214 |
1 |
0.011
|
|
|
|
ion transport
|
GO:0006811 |
114 |
0.011
|
|
|
|
regulation of signaling
|
GO:0023051 |
235 |
0.011
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
3 |
0.011
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
4 |
0.011
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
16 |
0.011
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
1 |
0.010
|
|
|
|
glucose homeostasis
|
GO:0042593 |
1 |
0.010
|
|
|
|
chemical homeostasis
|
GO:0048878 |
49 |
0.010
|
|
|
|
tissue remodeling
|
GO:0048771 |
4 |
0.010
|
|
|
|
embryonic neurocranium morphogenesis
|
GO:0048702 |
15 |
0.010
|
|
|
|
primitive erythrocyte differentiation
|
GO:0060319 |
5 |
0.010
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
3 |
0.010
|
|
|
|
regulation of protein binding
|
GO:0043393 |
3 |
0.010
|
|
|
|
response to organic substance
|
GO:0010033 |
153 |
0.010
|
|
|
|
female meiosis chromosome segregation
|
GO:0016321 |
1 |
0.010
|
|
|
|
protein import into nucleus
|
GO:0006606 |
3 |
0.010
|
|